UnitedHealth Group Inc (NYSE:UNH) – Investment analysts at SunTrust Banks upped their Q1 2020 earnings per share estimates for UnitedHealth Group in a note issued to investors on Wednesday, December 4th. SunTrust Banks analyst D. Macdonald now anticipates that the healthcare conglomerate will post earnings per share of $4.06 for the quarter, up from their prior forecast of $4.05. SunTrust Banks currently has a “Buy” rating and a $335.00 target price on the stock. SunTrust Banks also issued estimates for UnitedHealth Group’s Q4 2020 earnings at $4.15 EPS.
A number of other analysts have also weighed in on the company. BMO Capital Markets restated a “market perform” rating and issued a $310.00 target price on shares of UnitedHealth Group in a research note on Wednesday, December 4th. ValuEngine upgraded UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Credit Suisse Group raised their target price on UnitedHealth Group from $293.00 to $320.00 and gave the company an “outperform” rating in a research note on Wednesday, December 4th. Raymond James raised their target price on UnitedHealth Group from $300.00 to $320.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Finally, Piper Jaffray Companies raised their target price on UnitedHealth Group from $312.00 to $325.00 and gave the company an “overweight” rating in a research note on Wednesday, December 4th. Six equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $299.35.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The firm had revenue of $60.35 billion during the quarter, compared to analyst estimates of $59.84 billion. During the same period in the prior year, the company posted $3.41 earnings per share. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year.
A number of institutional investors have recently bought and sold shares of UNH. Nuveen Asset Management LLC boosted its holdings in UnitedHealth Group by 1,354.6% in the second quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock valued at $2,083,983,000 after acquiring an additional 7,953,416 shares during the last quarter. Boston Partners boosted its holdings in UnitedHealth Group by 160.8% in the second quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock valued at $622,942,000 after acquiring an additional 1,572,711 shares during the last quarter. Viking Global Investors LP boosted its holdings in UnitedHealth Group by 28.6% in the second quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock valued at $1,174,221,000 after acquiring an additional 1,071,149 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in UnitedHealth Group by 16.7% in the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after acquiring an additional 922,290 shares during the last quarter. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its holdings in UnitedHealth Group by 63.3% during the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,705,888 shares of the healthcare conglomerate’s stock worth $416,254,000 after buying an additional 661,064 shares during the last quarter. Institutional investors and hedge funds own 85.48% of the company’s stock.
In related news, EVP D Ellen Wilson sold 7,400 shares of the firm’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $232.76, for a total value of $581,900.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at approximately $43,753,992.04. The disclosure for this sale can be found here. In the last quarter, insiders sold 38,577 shares of company stock worth $9,398,080. 0.82% of the stock is owned by company insiders.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a yield of 1.55%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s dividend payout ratio is 33.54%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.